A new study with patient stem cell–based modeling of Smith-Lemli-Opitz syndrome (SLOS) shows that the accumulation of a specific cholesterol precursor dysregulates the Wnt/b-catenin pathway, which in turn leads to precocious neural differentiation.
References
Takahashi, K. et al. Cell 131, 861–872 (2007).
Bellin, M., Marchetto, M.C., Gage, F.H. & Mummery, C.L. Nat. Rev. Mol. Cell Biol. 13, 713–726 (2012).
Yoon, K.J. et al. Cell Stem Cell 15, 79–91 (2014).
Francis, K.R. et al. Nat. Med. 22, 388–396 (2016).
Porter, F.D. Eur. J. Hum. Genet. 16, 535–541 (2008).
Vanier, M.T. Orphanet J. Rare Dis. 5, 16 (2010).
Krakowiak, P.A. et al. Hum. Mol. Genet. 12, 1631–1641 (2003).
Ciani, L. & Salinas, P.C. Nat. Rev. Neurosci. 6, 351–362 (2005).
Jang, M.H. et al. Cell Stem Cell 12, 215–223 (2013).
Wen, Z. et al. Nature 515, 414–418 (2014).
Lancaster, M.A. & Knoblich, J.A. Science 345, 1247125 (2014).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wen, Z., Song, H. & Ming, Gl. Patient iPSCs: a new discovery tool for Smith-Lemli-Opitz syndrome. Nat Med 22, 343–344 (2016). https://doi.org/10.1038/nm.4081
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.4081
- Springer Nature America, Inc.